PD-L1 expression in leukemic cells could further attenuate CD8+ T cell activation, while blockage of PD-1/PD-L1 interaction reactivated CD8+ T cells in STAT5 high-expressed AML. The gene discussed is PDCD1; the disease is acute myeloid leukemia.